Sc. Barranco et al., Relationship between colorectal cancer glutathione levels and patient survival - Early results, DIS COL REC, 43(8), 2000, pp. 1133-1140
PURPOSE: Elevated glutathione is a cause of resistance to anticancer agents
and x-rays. The purpose of this study was to determine the frequency and c
linical significance of glutathione elevation in human colorectal cancer. M
ETHODS: Glutathione levels were measured in 41 colon cancers, 24 rectal can
cers, and corresponding normal tissues. The patients were then followed up
prospectively for tumor recurrence and survival. Survival was analyzed by t
he Kaplan-Meir method and Cox proportional hazards regression. RESULTS: Glu
tathione levels in primary colorectal cancers were significantly higher tha
n in the corresponding: normal tissues. Elevated glutathione levels had a s
ignificant negative effect on survival in patients with colorectal cancer,
whether based on the mean (P = 0.02) or median (P = 0.04) normal tissue lev
els. A negative effect of glutathione: levels on survival was apparent in p
atients with colorectal cancer, whether or not they were treated with posto
perative therapy. The larger the ratio of tumor glutathione to normal tissu
e glutathione, the poc,rer the prognosis. When adjusted fur other covariate
s, glutathione was still a significant predictor of survival. CONCLUSIONS:
An elevated tumor glutathione level at the time of diagnosis appears to con
fer a poor prognosis in patients with colorectal cancer. Longer-term study
using a larger number of patients will he required to confirm these finding
s, Knowledge of tumor glutathione content may help identify patients requir
ing more intensive therapy.